Thrombopoietin receptor agonists: a new immune modulatory strategy in immune thrombocytopenia?
Abstract
In 2008, new drugs that mimic the effects of thrombopoietin became available for the treatment of primary immune thrombocytopenia, eg, romiplostim and eltrombopag. These drugs activate the thrombopoietin receptor, stimulate the production of megakaryocytes, and increase the production of platelets. Important clinical observation has been gained, such as unexpected long-term remission after stopping thrombopoietin receptor agonists. The...
Paper Details
Title
Thrombopoietin receptor agonists: a new immune modulatory strategy in immune thrombocytopenia?
Published Date
Apr 1, 2016
Journal
Volume
53
Pages
S31 - S34
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History